Athina Papadopoulou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Athina Papadopoulou has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Eleni K. Efthimiadou
Laboratory of Inorganic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis-Zografou, 15771 Athens, Greece
3 shared publications - Charalampos Antachopoulos
Aristotle University of Thessaloniki, Greece
2 shared publications - John Dotis
Third Department of Pediatrics, Hippokration Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece
2 shared publications - Marios Kostakis
Laboratory of Analytical Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece
2 shared publications - Nikolaos S. Thomaidis
Laboratory of Analytical Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece
2 shared publications - Nikoleta Printza
First Department of Pediatrics, Hippokration Hospital, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece
2 shared publications
Latest Publications
- Open Access
- 1 June 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 48 (2)
Infecções por Moraxella relacionadas à diálise peritoneal: uma revisão sistemática
Resumo Introdução: Espécies de Moraxella, embora raras em infecções associadas à diálise peritoneal (DP), são patógenos estabelecidos. Moraxella catarrhalis causa infecções respiratórias, frequentemente associadas à produção de β-lactamase. Seu papel na DP merece investigação. Métodos: Buscou-se nas bases PubMed e Google Scholar casos de infecções por Moraxella em DP. Critérios de inclusão: diagnóstico de peritonite ou infecção no local de saída confirmados por cultura. Analisaramse dados demográficos, clínicos, microbiologia, resistência, terapêutica e desfechos. Resultados: Catorze casos de peritonite relacionada à Moraxella em pacientes em DP foram identificados entre 1987 e 2024, a partir de 13 estudos, sem relatos de infecções no local de saída. A idade média foi 56 anos; a nefropatia diabética foi a condição de base mais comum (quatro casos). M. catarrhalis (n = 6) e Moraxella osloensis (n = 5) foram os patógenos mais frequentes, com crescimento bacteriano apoiado em meios de cultura, seguido de identificação por perfis bioquímicos ou sistemas automatizados (n = 10), e técnicas confirmatórias avançadas empregadas quando relatadas. A apresentação clínica incluiu dor abdominal, febre e turbidez do líquido de diálise. A maioria dos isolados mostrou suscetibilidade a cefalosporinas, aminoglicosídeos e fluoroquinolonas. A maior parte dos pacientes (86%) manteve os cateteres após tratamento adequado, geralmente com administração intraperitoneal de cefalosporinas, com resolução completa dos sintomas em poucos dias. O prognóstico geral foi favorável, sem mortalidade. Conclusões: Espécies de Moraxella, embora raras, devem constar no diagnóstico diferencial das infecções relacionadas à DP. Sua identificação por técnicas avançadas permite tratamento eficaz e desfechos favoráveis, frequentemente sem necessidade de remoção do cateter.
- 1 June 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 48 (2)
Open AccessInfecções por Moraxella relacionadas à diálise peritoneal: uma revisão sistemática
Resumo Introdução: Espécies de Moraxella, embora raras em infecções associadas à diálise peritoneal (DP), são patógenos estabelecidos. Moraxella catarrhalis causa infecções respiratórias, frequentemente associadas à produção de β-lactamase. Seu papel na DP merece investigação. Métodos: Buscou-se nas bases PubMed e Google Scholar casos de infecções por Moraxella em DP. Critérios de inclusão: diagnóstico de peritonite ou infecção no local de saída confirmados por cultura. Analisaramse dados demográficos, clínicos, microbiologia, resistência, terapêutica e desfechos. Resultados: Catorze casos de peritonite relacionada à Moraxella em pacientes em DP foram identificados entre 1987 e 2024, a partir de 13 estudos, sem relatos de infecções no local de saída. A idade média foi 56 anos; a nefropatia diabética foi a condição de base mais comum (quatro casos). M. catarrhalis (n = 6) e Moraxella osloensis (n = 5) foram os patógenos mais frequentes, com crescimento bacteriano apoiado em meios de cultura, seguido de identificação por perfis bioquímicos ou sistemas automatizados (n = 10), e técnicas confirmatórias avançadas empregadas quando relatadas. A apresentação clínica incluiu dor abdominal, febre e turbidez do líquido de diálise. A maioria dos isolados mostrou suscetibilidade a cefalosporinas, aminoglicosídeos e fluoroquinolonas. A maior parte dos pacientes (86%) manteve os cateteres após tratamento adequado, geralmente com administração intraperitoneal de cefalosporinas, com resolução completa dos sintomas em poucos dias. O prognóstico geral foi favorável, sem mortalidade. Conclusões: Espécies de Moraxella, embora raras, devem constar no diagnóstico diferencial das infecções relacionadas à DP. Sua identificação por técnicas avançadas permite tratamento eficaz e desfechos favoráveis, frequentemente sem necessidade de remoção do cateter.
- Open Access
- 1 June 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 48 (2) , e20250246
Moraxella peritoneal dialysis-related infections: a systematic review
Introduction: Moraxella species, although infrequent in peritoneal dialysis (PD)-associated infections, are established pathogens. Moraxella catarrhalis is recognized as a cause of upper and lower respiratory tract infections and is increasingly associated with β-lactamase production. The role of Moraxella species in PD-related infections warrants further investigation. Methods: A comprehensive search of PubMed and Google Scholar was conducted for cases of PD-associated infections caused by Moraxella. Inclusion criteria required a diagnosis of peritonitis or exit-site infection confirmed by culture. Demographic data, clinical presentation, microbiological identification, antimicrobial resistance, therapeutic regimens, and outcomes were analyzed. Results: Fourteen cases of Moraxella-related peritonitis in PD patients were identified between 1987 and 2024 from 13 studies, with no reports of exitsite infections. The mean age was 56 years; diabetic nephropathy was the most common underlying condition (four cases). M. catarrhalis (n = 6) and Moraxella osloensis (n = 5) were the most frequent pathogens. The most commonly reported methods were bacterial growth in culture media, followed by species identification using biochemical profiling or automated systems (n = 10), and advanced confirmatory techniques. Clinical presentation included abdominal pain, fever, and clouding of the dialysis fluid. Most isolates were susceptible to cephalosporins, aminoglycosides, and fluoroquinolones. The majority of patients (86%) retained their catheters after appropriate treatment, usually with intraperitoneal cephalosporins, achieving complete symptom resolution within a few days. Overall prognosis was favorable, with no mortality. Conclusion: Moraxella species, although rare, should be considered in the differential diagnosis of PD-associated infections. Identification using advanced techniques allows effective treatment and favorable outcomes, often without the need for catheter removal.
- 1 June 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 48 (2) , e20250246
Open AccessMoraxella peritoneal dialysis-related infections: a systematic review
Introduction: Moraxella species, although infrequent in peritoneal dialysis (PD)-associated infections, are established pathogens. Moraxella catarrhalis is recognized as a cause of upper and lower respiratory tract infections and is increasingly associated with β-lactamase production. The role of Moraxella species in PD-related infections warrants further investigation. Methods: A comprehensive search of PubMed and Google Scholar was conducted for cases of PD-associated infections caused by Moraxella. Inclusion criteria required a diagnosis of peritonitis or exit-site infection confirmed by culture. Demographic data, clinical presentation, microbiological identification, antimicrobial resistance, therapeutic regimens, and outcomes were analyzed. Results: Fourteen cases of Moraxella-related peritonitis in PD patients were identified between 1987 and 2024 from 13 studies, with no reports of exitsite infections. The mean age was 56 years; diabetic nephropathy was the most common underlying condition (four cases). M. catarrhalis (n = 6) and Moraxella osloensis (n = 5) were the most frequent pathogens. The most commonly reported methods were bacterial growth in culture media, followed by species identification using biochemical profiling or automated systems (n = 10), and advanced confirmatory techniques. Clinical presentation included abdominal pain, fever, and clouding of the dialysis fluid. Most isolates were susceptible to cephalosporins, aminoglycosides, and fluoroquinolones. The majority of patients (86%) retained their catheters after appropriate treatment, usually with intraperitoneal cephalosporins, achieving complete symptom resolution within a few days. Overall prognosis was favorable, with no mortality. Conclusion: Moraxella species, although rare, should be considered in the differential diagnosis of PD-associated infections. Identification using advanced techniques allows effective treatment and favorable outcomes, often without the need for catheter removal.
- Open Access
- 3 September 2025
- Published by Royal Society of Chemistry (RSC) in Materials Advances
Engineering of two-in-one Fe@Eu nanoparticles through hydrothermal synthesis: bimetallic hybrids for theranostic applications
Dual-function Fe@Eu NPs made via co-precipitation show size- and composition-dependent bioactivity.
- 3 September 2025
- Published by Royal Society of Chemistry (RSC) in Materials Advances
Open AccessEngineering of two-in-one Fe@Eu nanoparticles through hydrothermal synthesis: bimetallic hybrids for theranostic applications
Dual-function Fe@Eu NPs made via co-precipitation show size- and composition-dependent bioactivity.
- Open Access
- 21 April 2025
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 6 (11) , 3561-3583
Hybrid silver–iron oxide nanoflowers: morphological tailoring, application as CT agents, and exploitation of induced apoptosis in glioblastoma treatment
The ability of cancer to develop drug-resistance, in parallel with the undesired effects of chemotherapy, has led to the development of safe nanoparticles characterized by multi-sensitivity.
- 21 April 2025
- Published by Royal Society of Chemistry (RSC) in Materials Advances
- Vol. 6 (11) , 3561-3583
Open AccessHybrid silver–iron oxide nanoflowers: morphological tailoring, application as CT agents, and exploitation of induced apoptosis in glioblastoma treatment
The ability of cancer to develop drug-resistance, in parallel with the undesired effects of chemotherapy, has led to the development of safe nanoparticles characterized by multi-sensitivity.
- Open Access
- 10 January 2022
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 51 (9) , 3452-3461
Synthesis, characterization and evaluation of aqueous Zn-based quantum dots for bioapplications
Quantum dots based on Zn like ZnO, ZnSe, ZnS, and doped ZnS : Mn and ZnS : Cd were developed via a simple sol–gel synthesis in an aqueous solution.
- 10 January 2022
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 51 (9) , 3452-3461
Open AccessSynthesis, characterization and evaluation of aqueous Zn-based quantum dots for bioapplications
Quantum dots based on Zn like ZnO, ZnSe, ZnS, and doped ZnS : Mn and ZnS : Cd were developed via a simple sol–gel synthesis in an aqueous solution.